Share URL
Embed chart view
StockViz
Telix Pharmaceuticals Limited
ASX:TLX.AX
Sector
Location
Market Cap
USD 3.62 B
Share Price
USD 10.84
Avg Daily Volume
1,711,983
Change (1 day)
-1.41%
Change (1 year)
-8.44%
Change (YTD)
-28.81%
Telix Pharmaceuticals Limited Share Price Year-To-Date (YTD) return on August 12, 2025: -28.81%
Telix Pharmaceuticals Limited Share Price Year-To-Date (YTD) return is -28.81% on August 12, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
-
Telix Pharmaceuticals Limited 52-week low Share Price is USD 19.75 on August 12, 2025, which is 82.17% above the current Share Price.
-
Telix Pharmaceuticals Limited 52-week low Share Price is USD 10.84 on August 12, 2025, which is 0.00% below the current Share Price.
-
Telix Pharmaceuticals Limited average Share Price for the last 52 weeks is USD 15.54.
Competitors
Roche Holding AG
USD 317.50
RO.SW
-1.30
-0.41%
Thermo Fisher Scientific Inc.
USD 462.39
TMO
+1.67
0.36%
Boston Scientific Corporation
USD 102.75
BSX
-0.39
-0.38%
Becton, Dickinson and Company
USD 192.50
BDX
-1.00
-0.52%
Fresenius SE & Co. KGaA
USD 50.88
FRE.DE
-0.04
-0.08%
Sartorius Stedim Biotech S.A.
USD 196.66
DIM.PA
+2.42
1.24%
bioMérieux S.A.
USD 144.74
BIM.PA
-0.44
-0.30%
United Therapeutics Corporation
USD 300.43
UTHR
-1.07
-0.36%
Medpace Holdings, Inc.
USD 449.77
MEDP
+15.42
3.55%
Revvity, Inc.
USD 85.80
RVTY
-1.04
-1.20%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.88
603392.SS
+0.01
0.07%
Sysmex Corporation
USD 13.98
6869.T
+0.14
1.00%
Exact Sciences Corporation
USD 40.91
EXAS
-0.08
-0.19%
Bio-Techne Corporation
USD 50.15
TECH
-0.27
-0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.49
002294.SZ
-0.12
-1.80%
Key Data
| Date | Share Price Year-To-Date (YTD) return | Price to Earnings Ratio (P/E) | Price to Book Ratio (P/B) | Price to Sales Ratio (P/S) |
|---|
Competitors
Roche Holding AG
USD 317.50
RO.SW
-1.30
-0.41%
Thermo Fisher Scientific Inc.
USD 462.39
TMO
+1.67
0.36%
Boston Scientific Corporation
USD 102.75
BSX
-0.39
-0.38%
Becton, Dickinson and Company
USD 192.50
BDX
-1.00
-0.52%
Fresenius SE & Co. KGaA
USD 50.88
FRE.DE
-0.04
-0.08%
Sartorius Stedim Biotech S.A.
USD 196.66
DIM.PA
+2.42
1.24%
bioMérieux S.A.
USD 144.74
BIM.PA
-0.44
-0.30%
United Therapeutics Corporation
USD 300.43
UTHR
-1.07
-0.36%
Medpace Holdings, Inc.
USD 449.77
MEDP
+15.42
3.55%
Revvity, Inc.
USD 85.80
RVTY
-1.04
-1.20%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.88
603392.SS
+0.01
0.07%
Sysmex Corporation
USD 13.98
6869.T
+0.14
1.00%
Exact Sciences Corporation
USD 40.91
EXAS
-0.08
-0.19%
Bio-Techne Corporation
USD 50.15
TECH
-0.27
-0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.49
002294.SZ
-0.12
-1.80%